ΤΡΙΑΝΤΑΦΥΛΛΟΣ ΣΤΥΛΙΑΝΟΠΟΥΛΟΣ
ΣΤΥΛΙΑΝΟΠΟΥΛΟΣ ΤΡΙΑΝΤΑΦΥΛΛΟΣ
STYLIANOPOULOS TRIANTAFYLLOS
...
ΑΝΑΠΛΗΡΩΤΗΣ/ΡΙΑ ΚΑΘΗΓΗΤΗΣ/ΡΙΑ
Τμήμα Μηχανικών Μηχανολογίας και Κατασκευαστικής
Green Park
Λεωφ. Αγλαντζιας 91
507
+357 2289 2238
+357 2289 5081
www.ucy.ac.cy/cancer_biophysics/en

Προσωπικό Προφίλ

Diploma in Chemical Engineering, 2003
National Technical University of Athens, Greece
 
PhD in Chemical Engineering, 2008
University of Minnesota, USA
 
Postdoctoral training, Department of Radiation Oncology
Massachusetts General Hospital / Harvard Medical School, USA
  
Triantafyllos received a Diploma in Chemical Engineering from National Technical University of Athens, Greece (GPA: 9.34/10) in 2003. The same year he joined the Chemical Engineering graduate program at the University of Minnesota, USA to pursue his doctoral studies. He worked with Professor Victor Barocas on modeling the mechanical response of native and bioartificial tissues. During his doctoral studies, he was elected twice top doctoral student of the department. After the completion of his PhD., in May 2008, Triantafyllos joined Dr. Rakesh Jain's lab in the department of Radiation Oncology at Harvard Medical School and Massachusetts General Hospital, USA for his prostodoctoral training. In Dr. Jain's lab he performed research in a mixture of experimental and computational problems for optimizing the delivery of molecular and nanoscale medicine to solid tumors. In September 2010, he joined the faculty of the Mechanical and Manufacturing Engineering department at the University of Cyprus.
 
Triantafyllos has co-authored over 115 publications in peer-review journals. His publication record includes five articles in Nature journals (Nature Nanotechnology, Nature Medicine, Nature Communications and two articles in Nature Reviews Clinical Oncology), eight articles in PNAS, two in Cancer Research as well as articles in Clinical Cancer Research and ACS Nano. h-index:41, > 10,000 citations (Web-of-Science) | h-index:47, > 13400 citations (GoogleScholar).
 
He has received 2 highly selective research grant by the European Research Council (ERC Starting Grant ReEngineeringCancer, 2014-2018, 1.44M euros and ERC Consolidator Grant Immuno-Predictor, 2020-2025, 2.0M euros) as well as the prestigious Y. C. Fung Early Carrer award by the American Society of Mechanical Engineers in 2016 (https://www.asme.org/about-asme/participate/honors-awards/achievement-awards/y-c-fung-young-investigator-award). Triantafyllos was also the recipient of the 2014 Most Cited Paper Award by the Biomedical Engineering Society (BMES) of the USA in 2014 and the New Researcher Award by the Research Promotion Foundation of Cyprus the same year.   
 
The last years, Triantafyllos has received as a Prinicipal Investigator ~ 6.0 Millions in Research funding, including 7 grants from FP7 and Horizon2020 and 2 grants from Research Promotion Foundation of Cyprus. 
 
Triantafyllos is a member of the American Society of Mechanical Engineers, the Biomedical Engineering Society of the USA, the European Foundation of Clinical Nanomedicine, the European Society of Biomechanics and the Greek Association of Computational Mechanics.

The major focus of my current research is on the biomechanics and drug delivery of solid tumors. I use experimental methods in mice bearing tumors and in vitro tumor models as well as mathematical modelling to study the evolution of mechanical forces in tumors and how these forces correlate with tumors' patho-physiology and delivery of chemotherapy, nanomedicine and immunotherapy. Furthermore, I investigate strategies to optimise tumor blood vessel functionality in order to improve systemic delivery of cancer therapeutics by modifying the mechanical tumor micro-environment.

 

Current Funding ID:

European Research Council Consolidator Grant (ERC-CoG): Immuno-Predictor: Mechanical Biomarkers for Cancer Immunotherapy Prediction. April 2020 - March 2025 , €2,000,000

Horizon 2020 - Marie Skłodowska-Curie Actions Individual Fellowship Global (MSCA-IF-GF-2020-101028945 CancerCOtreat): Optimizing treatment of cancer patients infected with COVID-19 and other preconditions using mathematical modelling. May 2021 – April 2024; €256,236.

Horizon 2020, European High-Performance Computing Joint Undertaking (H2020-JTI-EuroHPC-2019-1, No 956201): DComEX: Data Driven Computational Mechanics at EXascale, UCY budget: €250,000. April 2021-March 2024.

Research Promotion Foundation of Cyprus, (POST-DOC/0718/0084): Optimizing immunotherapy in triple-negative breast cancer by normalizing the tumor microenvironment. (ImmunoTNBC-TME) December 2019 - November 2022 €159,924

Research Promotion Foundation of Cyprus, New Strategic Infrastructure Units – Young Scientists, (CancerNanoMED): Center for Preclinical Evaluation and Optimization of Cancer Nanomedicines.  December 2018 - November 2022 €995,812

Please visit:

 http://www.ucy.ac.cy/cancer_biophysics/en/publications

 

Profile Information

Diploma in Chemical Engineering, 2003
National Technical University of Athens, Greece
 
PhD in Chemical Engineering, 2008
University of Minnesota, USA
 
Postdoctoral training, Department of Radiation Oncology
Massachusetts General Hospital / Harvard Medical School, USA
 

Triantafyllos received a Diploma in Chemical Engineering from National Technical University of Athens, Greece (GPA: 9.34/10) in 2003. The same year he joined the Chemical Engineering graduate program at the University of Minnesota, USA to pursue his doctoral studies. He worked with Professor Victor Barocas on modeling the mechanical response of native and bioartificial tissues. During his doctoral studies, he was elected twice top doctoral student of the department. After the completion of his PhD., in May 2008, Triantafyllos joined Dr. Rakesh Jain's lab in the department of Radiation Oncology at Harvard Medical School and Massachusetts General Hospital, USA for his prostodoctoral training. In Dr. Jain's lab he performed research in a mixture of experimental and computational problems for optimizing the delivery of molecular and nanoscale medicine to solid tumors. In September 2010, he joined the faculty of the Mechanical and Manufacturing Engineering department at the University of Cyprus.

Triantafyllos has co-authored over 115 publications in peer-review journals. His publication record includes five articles in Nature journals (Nature Nanotechnology, Nature Medicine, Nature Communications and two articles in Nature Reviews Clinical Oncology), eight articles in PNAS, two in Cancer Research as well as articles in Clinical Cancer Research and ACS Nano. h-index:41, > 10,000 citations (Web-of-Science) | h-index:47, > 13400 citations (GoogleScholar).

He has received 2 highly selective research grant by the European Research Council (ERC Starting Grant ReEngineeringCancer, 2014-2018, 1.44M euros and ERC Consolidator Grant Immuno-Predictor, 2020-2025, 2.0M euros) as well as the prestigious Y. C. Fung Early Carrer award by the American Society of Mechanical Engineers in 2016 (https://www.asme.org/about-asme/participate/honors-awards/achievement-awards/y-c-fung-young-investigator-award). Triantafyllos was also the recipient of the 2014 Most Cited Paper Award by the Biomedical Engineering Society (BMES) of the USA in 2014 and the New Researcher Award by the Research Promotion Foundation of Cyprus the same year.   

The last years, Triantafyllos has received as a Prinicipal Investigator ~ 6.0 Millions in Research funding, including 7 grants from FP7 and Horizon2020 and 2 grants from Research Promotion Foundation of Cyprus. 

Triantafyllos is a member of the American Society of Mechanical Engineers, the Biomedical Engineering Society of the USA, the European Foundation of Clinical Nanomedicine, the European Society of Biomechanics and the Greek Association of Computational Mechanics.

The major focus of my current research is on the biomechanics and drug delivery of solid tumors. I use experimental methods in mice bearing tumors and in vitro tumor models as well as mathematical modelling to study the evolution of mechanical forces in tumors and how these forces correlate with tumors' patho-physiology and delivery of chemotherapy, nanomedicine and immunotherapy. Furthermore, I investigate strategies to optimise tumor blood vessel functionality in order to improve systemic delivery of cancer therapeutics by modifying the mechanical tumor micro-environment.

Current Funding ID:

European Research Council Consolidator Grant (ERC-CoG): Immuno-Predictor: Mechanical Biomarkers for Cancer Immunotherapy Prediction. April 2020 - March 2025 , €2,000,000

Horizon 2020 - Marie Skłodowska-Curie Actions Individual Fellowship Global (MSCA-IF-GF-2020-101028945 CancerCOtreat): Optimizing treatment of cancer patients infected with COVID-19 and other preconditions using mathematical modelling. May 2021 – April 2024; €256,236.

Horizon 2020, European High-Performance Computing Joint Undertaking (H2020-JTI-EuroHPC-2019-1, No 956201): DComEX: Data Driven Computational Mechanics at EXascale, UCY budget: €250,000. April 2021-March 2024.

Research Promotion Foundation of Cyprus, (POST-DOC/0718/0084): Optimizing immunotherapy in triple-negative breast cancer by normalizing the tumor microenvironment. (ImmunoTNBC-TME) December 2019 - November 2022 €159,924

Research Promotion Foundation of Cyprus, New Strategic Infrastructure Units – Young Scientists, (CancerNanoMED): Center for Preclinical Evaluation and Optimization of Cancer Nanomedicines.  December 2018 - November 2022 €995,812

 Please visit 

http://www.ucy.ac.cy/cancer_biophysics/en/publications